Risk factor
High price volatility
Profitability factor
Very strong margins and returns
About
Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells. Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBI
Target Price
The average target price of 6712.TWO is 210 and suggests 49% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell